Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-03-23 Purchase | 2023-03-27 5:01 pm | DICE Therapeutics Inc. | DICE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 498,556 | $26.99 | $13,457,372 | 7,347,467 (Indirect) | View |
| 2023-03-17 Sale | 2023-03-21 4:47 pm | DICE Therapeutics Inc. | DICE | Scopa James Paul Director | 10,000 | $29.05 | $290,500 | 45,841 (Indirect Direct) | View |
| 2022-10-17 Purchase | 2022-10-19 4:32 pm | DICE Therapeutics Inc. | DICE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 1,640,000 | $36.5 | $59,860,000 | 6,848,911 (Indirect) | View |
| 2021-09-17 Purchase | 2021-09-20 9:19 pm | DICE Therapeutics Inc. | DICE | Northpond Ventures GP LLC Northpond Ventures LP Northpond Ventures GP II LLC Northpond Ventures II LP Rubin Michael P. 10% Owner | 235,000 | $17 | $3,995,000 | 3,292,871 (Indirect) | View |
| 2021-09-17 Purchase | 2021-09-20 4:30 pm | DICE Therapeutics Inc. | DICE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 1,400,000 | $17 | $23,800,000 | 786,407 (Indirect) | View |
| 2021-09-15 Purchase | 2021-09-16 9:30 pm | DICE Therapeutics Inc. | DICE | Scopa James Paul Director | 6,000 | $17 | $102,000 | 89,998 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-10-24 Gift | 2023-03-21 4:47 pm | N/A N/A | DICE Therapeutics Inc. | DICE | Scopa James Paul Director | 30,719 | $0 | 45,841 (Direct) | View |
| 2023-01-27 Option Award | 2023-01-31 5:44 pm | N/A 2033-01-26 | DICE Therapeutics Inc. | DICE | Robertson Scott M. CFO & CBO | 131,250 | $0 | 131,250 (Direct) | View |
| 2023-01-27 Option Award | 2023-01-31 5:37 pm | N/A 2033-01-26 | DICE Therapeutics Inc. | DICE | Timothy Lu CMO | 105,000 | $0 | 105,000 (Direct) | View |
| 2023-01-27 Option Award | 2023-01-31 5:30 pm | N/A 2033-01-26 | DICE Therapeutics Inc. | DICE | Judice Kevin CEO | 350,000 | $0 | 350,000 (Direct) | View |
| 2023-01-27 Option Award | 2023-01-31 5:25 pm | N/A 2033-01-26 | DICE Therapeutics Inc. | DICE | Jacobsen John R. CSO | 105,000 | $0 | 105,000 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-08 5:30 pm | N/A 2032-06-06 | DICE Therapeutics Inc. | DICE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 21,250 | $0 | 21,250 (Indirect) | View |
| 2022-06-07 Option Award | 2022-06-08 5:06 pm | N/A 2032-06-06 | DICE Therapeutics Inc. | DICE | TETLOW SHARON Director | 21,250 | $0 | 21,250 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-08 5:01 pm | N/A 2032-06-06 | DICE Therapeutics Inc. | DICE | Simson Jake Director | 21,250 | $0 | 21,250 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-08 4:53 pm | N/A 2032-06-06 | DICE Therapeutics Inc. | DICE | Scopa James Paul Director | 21,250 | $0 | 21,250 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-08 4:48 pm | N/A 2032-06-06 | DICE Therapeutics Inc. | DICE | SCHELLER RICHARD H Director | 31,250 | $0 | 31,250 (Direct) | View |
| 2022-04-14 Option Award | 2022-04-19 7:05 pm | N/A 2032-04-14 | DICE Therapeutics Inc. | DICE | Robertson Scott M. CFO & CBO | 154,250 | $0 | 154,250 (Direct) | View |
| 2022-04-14 Option Award | 2022-04-19 7:00 pm | N/A 2032-04-14 | DICE Therapeutics Inc. | DICE | Timothy Lu CMO | 157,756 | $0 | 157,756 (Direct) | View |
| 2022-04-14 Option Award | 2022-04-19 6:52 pm | N/A 2032-04-14 | DICE Therapeutics Inc. | DICE | Judice Kevin CEO | 384,900 | $0 | 384,900 (Direct) | View |
| 2022-04-14 Option Award | 2022-04-19 6:46 pm | N/A 2032-04-14 | DICE Therapeutics Inc. | DICE | Jacobsen John R. CSO | 154,250 | $0 | 154,250 (Direct) | View |
| 2022-03-31 Option Award | 2022-04-01 6:27 pm | N/A 2032-03-31 | DICE Therapeutics Inc. | DICE | Doyle Mittie Director | 42,500 | $0 | 42,500 (Direct) | View |
| 2022-03-31 Option Award | 2022-04-01 6:22 pm | N/A 2032-03-31 | DICE Therapeutics Inc. | DICE | Bowers Lisa Director | 42,500 | $0 | 42,500 (Direct) | View |
Ownership | 2022-04-01 6:12 pm | N/A N/A | DICE Therapeutics Inc. | DICE | Doyle Mittie Director | 0 | $0 | 0 (Direct) | View |
Ownership | 2022-04-01 6:06 pm | N/A N/A | DICE Therapeutics Inc. | DICE | Bowers Lisa Director | 0 | $0 | 0 (Direct) | View |
| 2021-12-30 Ownership | 2022-02-11 5:33 pm | N/A N/A | DICE Therapeutics Inc. | DICE | Scopa James Paul Director | 3,000 | $0 | 55,841 (Direct) | View |
| 2021-09-17 Conversion | 2021-09-20 9:19 pm | N/A N/A | DICE Therapeutics Inc. | DICE | Northpond Ventures GP LLC Northpond Ventures LP Northpond Ventures GP II LLC Northpond Ventures II LP Rubin Michael P. 10% Owner | 5,660,946 | $0 | 3,292,871 (Indirect) | View |
| 2021-09-17 Conversion | 2021-09-20 4:30 pm | N/A N/A | DICE Therapeutics Inc. | DICE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 7,617,822 | $0 | 786,407 (Indirect) | View |
| 2021-09-14 Option Award | 2021-09-16 9:30 pm | N/A 2031-09-14 | DICE Therapeutics Inc. | DICE | Scopa James Paul Director | 34,157 | $0 | 89,998 (Direct) | View |
| 2021-09-14 Option Award | 2021-09-16 9:28 pm | N/A 2031-09-14 | DICE Therapeutics Inc. | DICE | TETLOW SHARON Director | 34,157 | $0 | 83,998 (Direct) | View |
| 2021-09-14 Option Award | 2021-09-16 9:26 pm | N/A 2031-09-14 | DICE Therapeutics Inc. | DICE | SCHELLER RICHARD H Director | 44,356 | $0 | 136,880 (Direct) | View |
| 2021-09-14 Option Award | 2021-09-16 9:24 pm | N/A 2031-09-14 | DICE Therapeutics Inc. | DICE | Timothy Lu CMO | 100,064 | $0 | 262,349 (Direct) | View |
| 2021-09-14 Option Award | 2021-09-16 9:23 pm | N/A 2031-09-14 | DICE Therapeutics Inc. | DICE | Jacobsen John R. CSO | 95,856 | $0 | 280,862 (Direct) | View |
| 2021-09-14 Option Award | 2021-09-16 9:21 pm | N/A 2031-09-14 | DICE Therapeutics Inc. | DICE | Robertson Scott M. CFO & CBO | 129,011 | $0 | 345,761 (Direct) | View |
| 2021-09-14 Option Award | 2021-09-16 9:18 pm | N/A 2031-09-14 | DICE Therapeutics Inc. | DICE | Judice Kevin CEO | 300,226 | $0 | 1,113,609 (Direct) | View |
Ownership | 2021-09-14 9:25 pm | N/A N/A | DICE Therapeutics Inc. | DICE | Northpond Ventures GP LLC Northpond Ventures LP Northpond Ventures GP II LLC Northpond Ventures II LP Rubin Michael P. 10% Owner | 0 | $0 | 3,057,871 (Indirect) | View |
Ownership | 2021-09-14 7:37 pm | N/A N/A | DICE Therapeutics Inc. | DICE | Zachary Stephen Director | 0 | $0 | 0 (Direct) | View |
Ownership | 2021-09-14 7:34 pm | N/A N/A | DICE Therapeutics Inc. | DICE | Scopa James Paul Director | 0 | $0 | 69,000 (Direct) | View |
Ownership | 2021-09-14 7:32 pm | N/A N/A | DICE Therapeutics Inc. | DICE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 0 | $0 | 3,808,911 (Indirect) | View |
Ownership | 2021-09-14 7:30 pm | N/A N/A | DICE Therapeutics Inc. | DICE | Gandhi Shaan-Chirag C Director | 0 | $0 | 0 (Direct) | View |
Ownership | 2021-09-14 7:27 pm | N/A N/A | DICE Therapeutics Inc. | DICE | TETLOW SHARON Director | 0 | $0 | 69,000 (Direct) | View |
Ownership | 2021-09-14 7:23 pm | N/A N/A | DICE Therapeutics Inc. | DICE | SCHELLER RICHARD H Director | 0 | $0 | 113,000 (Direct) | View |
Ownership | 2021-09-14 7:20 pm | N/A N/A | DICE Therapeutics Inc. | DICE | Timothy Lu CMO | 0 | $0 | 215,835 (Direct) | View |
Ownership | 2021-09-14 7:15 pm | N/A N/A | DICE Therapeutics Inc. | DICE | Simson Jake Director | 0 | $0 | 0 (Direct) | View |
Ownership | 2021-09-14 7:10 pm | N/A N/A | DICE Therapeutics Inc. | DICE | Jacobsen John R. CSO | 0 | $0 | 231,625 (Direct) | View |